Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Dengue Treatment Guidelines

General Management Principles

  • The American College of Cardiology recommends symptomatic management as the cornerstone of dengue treatment, as there is no specific antiviral therapy currently approved, with a strength of evidence based on multiple studies 1, 2
  • Daily complete blood count monitoring is essential, particularly to track platelet counts and hematocrit levels in patients at risk of progression to shock, according to the Journal of Infection guidelines 1, 2
  • The American Heart Association advises avoiding aspirin and other non-steroidal anti-inflammatory drugs due to increased bleeding risk, based on evidence from the Journal of Infection 1, 2

Fluid Management

  • The American College of Cardiology recommends administering an initial fluid bolus of 20 mL/kg with careful patient reassessment afterward for patients with dengue shock syndrome, with a high strength of evidence 3, 4
  • For severe dengue shock syndrome, the Society of Critical Care Medicine suggests that colloid solutions may be beneficial when available, with a moderate strength of evidence 5, 6
  • For moderate dengue shock syndrome, the European Society of Intensive Care Medicine recommends crystalloid solutions as first-line, with a high strength of evidence 5, 6
  • Oral rehydration is appropriate for patients without signs of shock, according to the World Health Organization guidelines 5
  • The American College of Cardiology advises avoiding routine use of bolus intravenous fluids in patients with "severe febrile illness" who are not in shock, with a high strength of evidence 3, 4

Monitoring Parameters

  • The Society of Critical Care Medicine recommends watching for clinical indicators of adequate tissue perfusion, including normal capillary refill time, absence of skin mottling, warm and dry extremities, well-felt peripheral pulses, return to baseline mental status, and adequate urine output, with a high strength of evidence 5, 6
  • The American College of Cardiology advises monitoring for warning signs of progression to severe disease, including high hematocrit with rapidly falling platelet count, severe abdominal pain, persistent vomiting, lethargy or restlessness, and mucosal bleeding, with a moderate strength of evidence 1, 2, 7

Management of Complications

  • The European Society of Intensive Care Medicine recommends that for patients with persistent tissue hypoperfusion despite adequate fluid resuscitation, vasopressors such as dopamine or epinephrine may be required, with a moderate strength of evidence 5, 6
  • The American College of Cardiology advises avoiding overhydration, which can lead to pulmonary edema, particularly during the recovery phase, with a high strength of evidence 3, 8
  • The American Heart Association recommends that blood transfusion may be necessary in cases of significant bleeding, with a moderate strength of evidence 7

Common Pitfalls to Avoid

  • The American College of Cardiology warns that administering excessive fluid boluses in patients without shock can lead to fluid overload and respiratory complications, with a high strength of evidence 3, 4
  • The Journal of Infection guidelines advise against failing to recognize the critical phase (typically days 3-7 of illness) when plasma leakage can rapidly progress to shock, with a moderate strength of evidence 1, 7
  • The American Heart Association recommends avoiding the use of aspirin or NSAIDs, which can worsen bleeding tendencies, with a high strength of evidence 1, 2
  • The American College of Cardiology advises against delaying fluid resuscitation in patients with dengue shock syndrome, with a high strength of evidence 3, 4
  • The Journal of Infection guidelines recommend adequate monitoring of patients during the critical phase of illness, with a moderate strength of evidence 1

Management of Dengue Shock Syndrome

Initial Fluid Resuscitation

  • Administer 20 mL/kg of isotonic crystalloid as the initial bolus over 5-10 minutes, with reassessment and titration based on clinical response, and readiness to escalate to colloid solutions and vasopressors if shock persists, as recommended by the American College of Critical Care Medicine 9
  • If shock persists after the initial bolus, repeat crystalloid boluses up to a total of 40-60 mL/kg in the first hour may be necessary, according to the American College of Critical Care Medicine 9
  • Alternative colloids include gelafundin or albumin if dextran is unavailable, as suggested by the American College of Critical Care Medicine 9

Monitoring During Resuscitation

  • Watch for signs of fluid overload: hepatomegaly, rales on lung examination, or respiratory distress, as indicated by the American College of Critical Care Medicine 9
  • In resource-rich settings with persistent shock, consider invasive monitoring to guide therapy, as recommended by the American College of Critical Care Medicine 9

Management of Refractory Shock

  • For cold shock with hypotension: titrate epinephrine as first-line vasopressor, as suggested by the American College of Critical Care Medicine 9
  • For warm shock with hypotension: titrate norepinephrine as first-line vasopressor, according to the American College of Critical Care Medicine 9
  • Target mean arterial pressure appropriate for age and maintain ScvO2 >70%, as recommended by the American College of Critical Care Medicine 9

Key Clinical Pitfalls to Avoid

  • Do not continue aggressive fluid resuscitation once signs of fluid overload appear, switch to inotropic support instead, as advised by the American College of Critical Care Medicine 9
  • Do not use restrictive fluid strategies in established dengue shock syndrome, moderate-quality evidence shows no survival benefit from colloid restriction, and aggressive fluid management improves outcomes, as indicated by the American Heart Association 10 and the American College of Cardiology 11

Treatment of Dengue Shock Syndrome with Fluid Resuscitation

Initial Fluid Resuscitation

  • Moderate-quality evidence shows colloids provide faster resolution of shock compared to crystalloids alone (RR 1.09, 95% CI 1.00-1.19) 12

Fluid Management in Severe Dengue

Initial Fluid Resuscitation

  • The American Heart Association recommends administering 20 mL/kg of isotonic crystalloid as the initial bolus over 5-10 minutes for dengue shock syndrome, with moderate-quality evidence demonstrating colloids achieve faster resolution of shock compared to crystalloids alone (RR 1.09, 95% CI 1.00-1.19) 13
  • Moderate-quality evidence shows that colloids reduce the total volume of initial bolus needed (mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids) 13

Critical Pitfalls to Avoid

  • The American College of Cardiology suggests avoiding routine bolus IV fluids in patients with severe febrile illness who are NOT in shock, as this increases risk of fluid overload and respiratory complications without improving outcomes 13
  • Moderate-quality evidence shows no survival benefit from colloid restriction, and restrictive fluids in severe malaria showed harm with increased need for rescue fluid (17.6% versus 0.0%; P<0.005) 14

Fluid Management in Pediatric Dengue Patients

Initial Resuscitation

  • The American Heart Association recommends using crystalloids as the first-line fluid for resuscitation in pediatric dengue patients, with colloids reserved for severe cases, as moderate-quality evidence shows colloids reduce the total volume of initial bolus needed (mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids) 15

Fluid Overload Prevention

  • The World Health Organization suggests avoiding aggressive fluid resuscitation once signs of fluid overload appear, and instead switching to inotropic support, as evidence from a study demonstrated that aggressive shock management combined with judicious fluid removal decreased pediatric ICU mortality from 16.6% to 6.3% 15

Hydration Strategy for Dengue Fever

Initial Assessment and Hydration Protocol

  • The Centers for Disease Control and Prevention recommends using any locally available fluids, including water, oral rehydration solutions, cereal-based gruels, soup, and rice water, for hydration, and avoiding soft drinks due to high osmolality 16, 17
  • The World Health Organization suggests a practical approach to hydration by encouraging 5 or more glasses of fluid throughout the day, with a target fluid intake of approximately 2,500-3,000 mL daily, based on evidence showing this volume reduces hospitalization rates 16, 17

Supportive Care

  • The American Academy of Pediatrics recommends resuming age-appropriate diet as soon as appetite returns, and using acetaminophen (paracetamol) only for pain and fever management, while avoiding aspirin and NSAIDs 16, 17

Management of Dengue Shock Syndrome with Severe Hypotension

Immediate Resuscitation Protocol

  • The American College of Critical Care Medicine recommends administering 20 mL/kg of Ringer's lactate or 0.9% normal saline as a rapid bolus over 5-10 minutes, with reassessment for signs of improvement after each bolus, and repeating crystalloid boluses up to a total of 40-60 mL/kg in the first hour before escalating therapy, with evidence strongly supporting aggressive initial fluid resuscitation in dengue shock syndrome, demonstrating near 100% survival with appropriate fluid management 18
  • Improvement in tachycardia and tachypnea is a sign of adequate resuscitation 19

Critical Monitoring Parameters

  • Stop fluid resuscitation immediately if hepatomegaly or pulmonary rales develop, and monitor for respiratory distress, which signals the need to switch from fluids to inotropic support 18

Management of Refractory Shock

  • Begin peripheral inotropic support immediately if central venous access is not readily available, as delays in vasopressor therapy are associated with major increases in mortality, with the choice of vasopressor matching the hemodynamic state, such as epinephrine for cold shock or norepinephrine for warm shock 18, 20

Critical Pitfalls to Avoid

  • Delaying fluid resuscitation in established dengue shock syndrome significantly increases mortality, and once hypotension occurs, cardiovascular collapse may rapidly follow, with blood pressure alone not being a reliable endpoint in children 18
  • Restrictive fluid strategies have no survival benefit in dengue shock syndrome and may worsen outcomes, with three RCTs demonstrating near 100% survival with aggressive fluid management, and the FEAST trial being conducted in a different clinical context 18, 19, 21

Management of Severe Dengue

Classification and Management

  • The World Health Organization recommends classifying dengue into three distinct categories: dengue without warning signs, dengue with warning signs, and severe dengue, which determines the management approach 22
  • Severe dengue includes dengue shock syndrome, severe bleeding, or organ impairment, with a mortality rate of 1-5% without proper management, but can be reduced to <0.5% with proper clinical care 23, 22

ICU Management of Severe Dengue

  • The Centers for Disease Control and Prevention recommends immediate ICU admission and aggressive fluid resuscitation for severe dengue, with a first bolus of 20 mL/kg of 0.9% Normal Saline or Ringer's Lactate over 5-10 minutes 22
  • Moderate-quality evidence shows that colloids achieve faster resolution of shock and reduce total volume needed, with a relative risk of 1.09 22

Fluid Management for Dengue in Children

Initial Resuscitation

  • For children with dengue shock syndrome, administer an initial bolus of 20 mL/kg of isotonic crystalloid over 5-10 minutes, with immediate reassessment after each bolus and readiness to repeat up to 40-60 mL/kg in the first hour if shock persists, as recommended by the American Heart Association 24, 25
  • The American College of Critical Care Medicine suggests that aggressive crystalloid resuscitation is life-saving and achieves near 100% survival when properly administered in children with dengue shock syndrome 25

Fluid Management Protocol

  • The American Heart Association recommends that critical pitfall to avoid is giving routine bolus IV fluids to children with "severe febrile illness" who are not in shock, as this increases fluid overload and respiratory complications without improving outcomes 24
  • The American College of Critical Care Medicine suggests that for severe dengue shock, colloids may provide faster shock resolution and require less total volume, though clinical outcomes are similar 24

Monitoring Parameters

  • The American College of Critical Care Medicine recommends tracking hematocrit monitoring, as rising hematocrit indicates ongoing plasma leakage and need for continued resuscitation, and falling hematocrit suggests successful plasma expansion 25

Management of Refractory Shock

  • The American College of Critical Care Medicine suggests that if shock persists despite 40-60 mL/kg of crystalloid in the first hour, switch strategy from aggressive fluid administration to inotropic support rather than continuing fluid boluses, and target mean arterial pressure appropriate for age and ScvO2 >70% 25

Post-Resuscitation Fluid Management

  • The American College of Critical Care Medicine recommends that after initial shock reversal, fluid removal may be necessary, and evidence shows that aggressive shock management followed by judicious fluid removal decreased pediatric ICU mortality from 16.6% to 6.3% 25
  • The American College of Critical Care Medicine suggests considering continuous renal replacement therapy (CRRT) if fluid overload >10% develops, as outcomes are better when CRRT is initiated early 25

Supportive Care

  • The American College of Critical Care Medicine recommends blood transfusion may be necessary for significant bleeding, and target hemoglobin >10 g/dL if ScvO2 <70% 25

Management of Refractory Shock in Dengue Fever

Vasopressor Therapy

  • For warm shock with hypotension, the American College of Critical Care Medicine recommends titrating norepinephrine as first-line vasopressor 26

Special Considerations

  • The World Health Organization suggests that after initial shock reversal, judicious fluid removal may be necessary during the recovery phase, with evidence showing that aggressive shock management followed by fluid removal decreased pediatric ICU mortality 26

Blood Pressure Cutoffs for Pediatric Dengue Shock Syndrome

Critical Concept: Blood Pressure is NOT the Primary Diagnostic Criterion

  • In pediatric patients, shock can be present with normal blood pressure, making BP cutoffs less clinically useful than perfusion markers for early recognition of dengue shock syndrome 27
  • The American College of Critical Care Medicine recommends using age-specific mean arterial pressure targets during resuscitation, though specific numerical cutoffs vary by age and are not explicitly stated in dengue-specific guidelines 27

Target MAP During Resuscitation

  • The American College of Critical Care Medicine recommends targeting age-appropriate mean arterial pressure while maintaining ScvO2 >70% during resuscitation of pediatric dengue shock syndrome patients 27

Hematocrit‑Based Diagnosis and Monitoring in Severe Dengue

Diagnostic Thresholds for Severe Dengue

  • The Centers for Disease Control and Prevention (CDC) define dengue hemorrhagic fever by a ≥20 % increase in hematocrit from the patient’s baseline, reflecting significant plasma leakage and progression to severe disease【28】.
  • A ≥20 % rise in hematocrit above baseline is the specific laboratory criterion that distinguishes dengue hemorrhagic fever from uncomplicated dengue infection【28】.
  • This hemoconcentration indicates plasma leakage caused by increased capillary permeability, which is the pathophysiologic hallmark of severe dengue【28】.
  • Dengue shock syndrome requires the same ≥20 % hematocrit increase plus either hypotension or a narrow pulse pressure (≤20 mm Hg)【28】.

Limitations of Single or Serial Hematocrit Measurements

  • A single hematocrit value should not be used alone to infer bleeding or disease severity because its sensitivity for identifying patients who need surgical intervention is low (≈0.5)【29】【30】.
  • Serial hematocrit readings are confounded by ongoing fluid resuscitation and blood‑product transfusion, which reduces their diagnostic accuracy for tracking plasma leakage【29】【30】.

Clinical Warning Signs of Fluid Overload During Resuscitation

  • Development of hepatomegaly during fluid therapy signals impending fluid overload and should prompt cessation of further crystalloid boluses【29】.
  • Presence of pulmonary rales on auscultation is a warning sign of fluid overload in patients receiving dengue resuscitation【29】.
  • New‑onset respiratory distress while resuscitating indicates excessive fluid accumulation and the need to modify the fluid strategy【29】.

Assessment of Shock in Dengue Critical Phase

Clinical Indicators of Dengue Shock Syndrome

  • A capillary refill time of ≥ 3 seconds in a patient with suspected dengue during the critical phase is a key indicator of dengue shock syndrome and should prompt immediate fluid resuscitation with isotonic crystalloid bolus. 31

REFERENCES